125 related articles for article (PubMed ID: 29040002)
1. FAK-Src-paxillin system expression and disease outcome in human neuroblastoma.
Kratimenos P; Koutroulis I; Syriopoulou V; Michailidi C; Delivoria-Papadopoulos M; Klijanienko J; Theocharis S
Pediatr Hematol Oncol; 2017 May; 34(4):221-230. PubMed ID: 29040002
[TBL] [Abstract][Full Text] [Related]
2. Multi-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase-Src-Paxillin system.
Kratimenos P; Koutroulis I; Marconi D; Syriopoulou V; Delivoria-Papadopoulos M; Chrousos GP; Theocharis S
Expert Opin Ther Targets; 2014 Dec; 18(12):1395-406. PubMed ID: 25189706
[TBL] [Abstract][Full Text] [Related]
3. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
5. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.
Wu L; Bernard-Trifilo JA; Lim Y; Lim ST; Mitra SK; Uryu S; Chen M; Pallen CJ; Cheung NK; Mikolon D; Mielgo A; Stupack DG; Schlaepfer DD
Oncogene; 2008 Feb; 27(10):1439-48. PubMed ID: 17828307
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.
Beierle EA; Ma X; Trujillo A; Kurenova EV; Cance WG; Golubovskaya VM
Mol Carcinog; 2010 Mar; 49(3):224-34. PubMed ID: 19885861
[TBL] [Abstract][Full Text] [Related]
9. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
[TBL] [Abstract][Full Text] [Related]
11. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
12. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
[TBL] [Abstract][Full Text] [Related]
13. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
Hu HL; He LJ
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
[TBL] [Abstract][Full Text] [Related]
14. Paxillin modulates squamous cancer cell adhesion and is important in pressure-augmented adhesion.
Conway WC; Van der Voort van Zyp J; Thamilselvan V; Walsh MF; Crowe DL; Basson MD
J Cell Biochem; 2006 Aug; 98(6):1507-16. PubMed ID: 16552730
[TBL] [Abstract][Full Text] [Related]
15. Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells.
Park HB; Golubovskaya V; Xu L; Yang X; Lee JW; Scully S; Craven RJ; Cance WG
Biochem J; 2004 Mar; 378(Pt 2):559-67. PubMed ID: 14629195
[TBL] [Abstract][Full Text] [Related]
16. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
[TBL] [Abstract][Full Text] [Related]
17. B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.
Ho WL; Che MI; Chou CH; Chang HH; Jeng YM; Hsu WM; Lin KH; Huang MC
Cancer Sci; 2013 Dec; 104(12):1600-8. PubMed ID: 24118321
[TBL] [Abstract][Full Text] [Related]
18. LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis.
Dorneburg C; Fischer M; Barth TFE; Mueller-Klieser W; Hero B; Gecht J; Carter DR; de Preter K; Mayer B; Christner L; Speleman F; Marshall GM; Debatin KM; Beltinger C
Clin Cancer Res; 2018 Nov; 24(22):5772-5783. PubMed ID: 29925504
[No Abstract] [Full Text] [Related]
19. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
[TBL] [Abstract][Full Text] [Related]
20. N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
Beierle EA; Trujillo A; Nagaram A; Kurenova EV; Finch R; Ma X; Vella J; Cance WG; Golubovskaya VM
J Biol Chem; 2007 Apr; 282(17):12503-16. PubMed ID: 17327229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]